beta-(6,8-Dibromo-2-methyl-3,4-dihydro-4-oxoquinazolin-3-yl)ethyl benzylaminoacetate
Molecular Formula:
C20H19Br2N3O3
InChI: InChI=1/C20H19Br2N3O3/c1-13-24-19-16(9-15(21)10-17(19)22)20(27)25(13)7-8-28-18(26)12-23-11-14-5-3-2-4-6-14/h2-6,9-10,23H,7-8,11-12H2,1H3
InChIKey: InChIKey=CVXAXBDYMCJDCF-UHFFFAOYAF
SMILES: CC1=NC2=C(C=C(C=C2C(=O)N1CCOC(=O)CNCC3=CC=CC=C3)Br)Br
Names:
beta-(6,8-Dibromo-2-methyl-3,4-dihydro-4-oxoquinazolin-3-yl)ethyl benzylaminoacetate
Glycine, N-(phenylmethyl)-, 2-(6,8-dibromo-2-methyl-4-oxo-3(4H)-quinazolinyl)ethyl ester
GLYCINE, N-(PHENYLMETHYL)-, 2-(6,8-DIBROMO-2-METHYL-4-OXO-3(4H)-QUINAZOLINYL)ETH
N-(Phenylmethyl)glycine 2-(6,8-dibromo-2-methyl-4-oxo-3(4H)-quinazolinyl)ethyl ester
110009-15-9
2-(6,8-dibromo-2-methyl-4-oxo-quinazolin-3-yl)ethyl 2-(benzylamino)acetate
Registries:
PubChem CID 60393
PubChem ID 196708
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|